Topics

Century Therapeutics brings in $250mm via Series A

15:40 EDT 8 Jul 2019 | Elsevier Business Intelligence

Cell therapy start-up Century Therapeutics raised $250mm through its Series A round. Bayer AG, through its newly minted Leaps...

Original Article: Century Therapeutics brings in $250mm via Series A

NEXT ARTICLE

More From BioPortfolio on "Century Therapeutics brings in $250mm via Series A"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...